BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

May 3, 2023

Study Completion Date

May 3, 2023

Conditions
Colitis, Ulcerative
Interventions
DRUG

Spesolimab

Solution

Trial Locations (38)

1090

AKH - Medical University of Vienna, Vienna

3000

UZ Leuven, Leuven

4000

Centre Hospitalier Universitaire de Liège, Liège

4010

Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz

10032

Columbia University Medical Center-New York Presbyterian Hospital, New York

20089

Istituto Clinico Humanitas, Rozzano (MI)

22559

Asklepios Kliniken Westklinikum Hamburg, Hamburg

23249

Hunter Holmes McGuire VA Medical Center, Richmond

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

30322

Emory University, Atlanta

30625

Medizinische Hochschule Hannover, Hanover

35128

Azienda Ospedaliera Universitaria di Padova, Padua

41013

Hospital Virgen del Rocío, Seville

42415

Yeungnam University Medical Center, Daegu

46026

Hospital Politècnic La Fe, Valencia

48108

Inje University Haeundae Paik Hospital, Busan

60637

University of Chicago, Chicago

73112

Digestive Disease Specialists Inc, Oklahoma City

73730

Klinikum Esslingen GmbH, Esslingen am Neckar

76092

Texas Digestive Disease Consultants - Southlake, Southlake

78229

Southern Star Research Institute, LLC, San Antonio

89081

Universitätsklinikum Ulm, Ulm

91054

Universitätsklinikum Erlangen, Erlangen

123423

"Federal State Budgetary Institution State Scientific Center of Coloproctology MOH Russia", Moscow

194044

Military Medical Academy n.a. C. M. Kirov, St. Petersburg, Saint Petersburg

664033

FSB Instit. HC Irkutsk Scient.Cent. Sibirian Branch of Russ. Acad. Scien., Irkutsk

06518

Medical Research Center of Connecticut, LLC, Hamden

N6A 5W9

Victoria Hospital (LHSC), London

004-0041

Sapporo Tokushukai Hospital, Hokkaido, Sapporo

065-0033

Sapporo Higashi Tokushukai Hospital, Hokkaido, Sapporo

663-8501

Hyogo College of Medicine Hospital, Hyogo, Nishinomiya

247-0056

Ofuna Chuo Hospital, Kanagawa, Kamakura

113-8519

Tokyo Medical and Dental University Hospital, Tokyo, Bunkyo-ku

169-0073

Tokyo Yamate Medical Center, Tokyo, Shinjuku

02-507

National Medical Institute MSWiA, Warsaw

DN2 5LT

Doncaster Royal Infirmary, Doncaster

SE1 9RT

Guy's Hospital, London

L35 5DR

Whiston Hospital, Prescot

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03648541 - BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis | Biotech Hunter | Biotech Hunter